Expression of TGFBI in infantile hemangioma tissues and its effect on the biological characteristics of hemangioma endothelial cells

doi:10.7518/hxkq.2023.01.004

Abstract

Abstract:

Objective This study aimed to investigate the expression of TGFBI in infantile hemangioma (IH) of proliferative stage or involuting stage and detect the effects of TGFBI overexpression or knockdown on the biological beha-vior of hemangioma endothelial cells (HemECs) from proliferative IH by using plasmid and siRNA. Methods TGFBI expression levels in proliferative IH and involuting IH were detected by immunofluorescence. TGFBI overexpression plasmid and negative control plasmid were constructed and transfected into HemECs. siRNA for TGFBI and its negative control siRNA were constructed and transfected into HemECs. Western blot was used to detect the expression of TGFBI in the TGFI overexpression group (OE group) and its negative control (NC group), as well as TGFBI knockdown group (si-TGFBI group) and its negative control (si-NC group), to confirm the efficiency of transfection. CCK-8 assays were performed to assess the viability of HemECs. EdU assays were conducted to investigate the proliferation ability of HemECs. Transwell assays were used to detect the migration ability of HemECs. Tube formation assays were carried out to assess the angiogenic capacity of HemECs. Extracellular acidification rate (ECAR) assays were performed to investigate the glycolysis level of HemECs. Results The results of immunofluorescence showed that TGFBI expression was significantly elevated in proliferative IH compared with that in involuting IH. Western blot showed that TGFBI expression in the OE group was upregulated compared with that in the NC group, and TGFBI expression in si-TGFBI was downregulated compared with that in the si-NC group. The viability, cell proliferation, migration ability, and angiogenic capacity of HemECs were promoted in the OE group compared with those in the NC group, whereas these biological behaviors were inhibited in the si-TGFBI group compared with those in the si-NC group. In ECAR assays, the glycolysis level of HemECs in the OE group was enhanced compared with that in the NC group. Conclusion TGFBI is upregulated in proliferative IH. TGFBI overexpression enhanced the viability, cell proliferation, migration ability, and angiogenic capacity of HemECs, which indicated that TGFBI might play a key role in IH progression by accelerating glycolysis. Thus, targeting TGFBI might be an effective therapeutic strategy for IH.

Key words: infantile hemangioma, TGFBI, plasmid, proliferation, migration, tube formation, glycolysis

CLC Number:

R 739.8

Li Mingyang, Yang Enli, Li Yiming, Geng Yiming, Wu Haiwei, Zhang Dongsheng. Expression of TGFBI in infantile hemangioma tissues and its effect on the biological characteristics of hemangioma endothelial cells[J]. West China Journal of Stomatology, 2023, 41(1): 29-36.

Figures/Tables 7

Fig 1

Fig 2

Fig 3

Fig 4

Fig 5

Fig 6

Fig 7

References 20

1	Leaute-Labreze C, Harper JI, Hoeger PH. Infantile haemangioma[J]. Lancet, 2017, 390(10089): 85-94.
2	Itinteang T, Withers AH, Davis PF, et al. Biology of infantile hemangioma[J]. Front Surg, 2014, 1: 38.
3	Zavras N, Dimopoulou A, Machairas N, et al. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives[J]. Eur J Pediatr, 2020, 179(1): 1-8.
4	Koh SP, Leadbitter P, Smithers F, et al. Β-blocker therapy for infantile hemangioma[J]. Expert Rev Clin Pharmacol, 2020, 13(8): 899-915.
5	Skonier J, Neubauer M, Madisen L, et al. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta[J]. DNA Cell Biol, 1992, 11(7): 511-522.
6	Thapa N, Lee BH, Kim IS. TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta[J]. Int J Biochem Cell Biol, 2007, 39(12): 2183-2194.
7	Ma C, Rong Y, Radiloff DR, et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation[J]. Genes Dev, 2008, 22(3): 308-321.
8	Costanza B, Rademaker G, Tiamiou A, et al. Transfor-ming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration[J]. Int J Cancer, 2019, 145(6): 1570-1584.
9	Chiavarina B, Costanza B, Ronca R, et al. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis[J]. Theranostics, 2021, 11(4): 1626-1640.
10	Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis[J]. Nat Rev Cancer, 2008, 8(8): 604-617.
11	Laken PA. Infantile hemangiomas: pathogenesis and review of propranolol use[J]. Adv Neonatal Care, 2016, 16(2): 135-142.
12	Goelz R, Poets CF. Incidence and treatment of infantile haemangioma in preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2015, 100(1): F85-F91.
13	Drolet BA, Frieden IJ. Characteristics of infantile he-mangiomas as clues to pathogenesis: does hypoxia connect the dots[J]. Arch Dermatol, 2010, 146(11): 1295-1299.
14	Boye E, Olsen BR. Signaling mechanisms in infantile hemangioma[J]. Curr Opin Hematol, 2009, 16(3): 202-208.
15	Przewratil P, Sitkiewicz A, Andrzejewska E. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth[J]. Cytokine, 2010, 49(2): 141-147.
16	Przewratil P, Kobos J, Wnęk A, et al. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment[J]. Immunol Lett, 2016, 175: 44-49.
17	Gupta K, Kshirsagar S, Li W, et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling[J]. Exp Cell Res, 1999, 247(2): 495-504.
18	Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survi-val through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation[J]. J Biol Chem, 1998, 273(46): 30336-30343.
19	Corona A, Blobe GC. The role of the extracellular matrix protein TGFBI in cancer[J]. Cell Signal, 2021, 84: 110028.
20	Chen J, Wu D, Dong Z, et al. The expression and role of glycolysis-associated molecules in infantile hemangioma[J]. Life Sci, 2020, 259: 118215.

[1]	Ding Xiao, Chen Jiawen, Qu Pengyu, Sun Chenyu, Li Hongli, Hu Wenting, Fan Xin. miR-362-3p inhibited the invasion and metastasis of oral squamous cell carcinoma cells by targeting the regulation of pituitary tumor-transforming gene 1 [J]. West China Journal of Stomatology, 2024, 42(1): 46-55.
[2]	Hou Yali, Li Hexiang, Song Peng, Yang Yanxiao, Hao Yali, Liu Huijuan. Effect of tumor-stromal fibroblasts on the biological behavior of salivary gland pleomorphic adenoma cells in vitro [J]. West China Journal of Stomatology, 2023, 41(2): 149-156.
[3]	Wang Xianwen, Chen Qianming, Jiang Lu.. Radiation-induced oral mucositis presenting as atypical vascular proliferation: a case report [J]. West China Journal of Stomatology, 2022, 40(6): 721-726.
[4]	Cong Biqiao, Liu Xiaoping, Chen Jiawen, Li Hongli, Fan Xin. Effect of microRNA-663b on migration, invasion and epithelial‑mesenchymal transition of oral squamous cell carcinoma cells [J]. West China Journal of Stomatology, 2022, 40(4): 386-393.
[5]	Li Wenjian, Tong Lei, Wang Qimin, Han Hongyu, Chen Zhenggang. Effects of silencing farnesyltransferase on the migration, invasion, and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells [J]. West China Journal of Stomatology, 2022, 40(4): 394-402.
[6]	Chen Jiao, Die Lü, Chen Hongli, Zhang Ping.. Effect of protein kinase D inhibitor CRT0066101 on the cell migration of salivary adenoid cystic carcinoma [J]. West China Journal of Stomatology, 2022, 40(3): 320-327.
[7]	Wei Zhuo, Zhou Hao, Fei Wei, Nie Xiong, Li Mingfang. Effect of SOX2 gene on the biological characteristics of salivary adenoid cystic carcinoma cells [J]. West China Journal of Stomatology, 2022, 40(3): 341-349.
[8]	Zhang Yuwei, He Yuxuan, Ding Yi, Liu Chengcheng.. Porphyromonas gingivalis upregulates calbindin 1 and thus promotes the proliferation of gingival epithelial cells [J]. West China Journal of Stomatology, 2022, 40(1): 93-99.
[9]	Gao Yongqiang, Shi Pengwei, Shi Wenkai, Liu Yiming. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma [J]. West China Journal of Stomatology, 2021, 39(6): 658-666.
[10]	Zhao Kai, Yuan Wenhong, Li Wenjian, Chi Zengpeng, Wang Shaoru, Chen Zhenggang. Effect of RhoE expression on the migration and invasion of tongue squamous cell carcinoma [J]. West China Journal of Stomatology, 2021, 39(5): 510-517.
[11]	Dai Xiaohua, Wang Guanhua, Lian Xiaoli, Yan Yan, Wang Yue, Zou Huiru, Liu Hao.. Effect of acidic culture conditions on the proliferation, apoptosis, and migration ability of human tongue squamous cell carcinoma cells and its related mechanism [J]. West China Journal of Stomatology, 2021, 39(5): 540-546.
[12]	Pang Ming, Wei Hongxia, Chen Xi. Long non-coding RNA potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 regulates the proliferation and osteogenic differentiation of human periodontal ligament stem cells by targeting miR-24-3p [J]. West China Journal of Stomatology, 2021, 39(5): 547-554.
[13]	Zhou Haixia, Wang Luyao, Chen Shuai, Wang Dandan, Fang Zheng. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis [J]. West China Journal of Stomatology, 2021, 39(4): 425-433.
[14]	Jia Mei’e, Li Zhiyong, Xu Kai, Wang Yiheng, Yu Fei, He Xiangyi. Biological effects of exosome derived from Cal27 on normal human gingival fibroblasts [J]. West China Journal of Stomatology, 2021, 39(3): 313-319.
[15]	Lin Chengzhong, Liu Zheqi, Zhou Wenkai, Ji Tong, Cao Wei. Effect of the regulator of G-protein signaling 2 on the proliferation and invasion of oral squamous cell carcinoma cells and its molecular mechanism [J]. West China Journal of Stomatology, 2021, 39(3): 320-327.